David S. Ludwig, MD, PhD; Jens J. Holst, MD, DMSc
JAMA. 2023;329(22):1909-1910. doi:10.1001/jama.2023.7592
This Viewpoint considers the best approaches for treating obesity in youth and argues that better funding is needed for new dietary treatments and reimbursement for behavioral interventions.
Sravya Chary, MBE, MS; Danielle Pacia, MBE; Carmel Shachar, JD, MPH
has audio
JAMA. 2023;329(22):1911-1912. doi:10.1001/jama.2023.6278
This Viewpoint discusses the legal risks physicians and health care facilities may incur by miscoding a surgical or chemical abortion as a miscarriage to conceal an abortion procedure.
-
Audio:
Legal Risks of Abortion Miscoding
Omri David Soffer, MD; Teri J. Mauch, MD, PhD; Melissa A. Muff-Luett, MD
JAMA. 2023;329(22):1913-1914. doi:10.1001/jama.2023.6329
This Viewpoint discusses the long-term medical, emotional, and financial implications of using amnioinfusion to treat anhydramnios; outlines the ongoing Renal Anhydramnios Fetal Therapy (RAFT) trial, which aims to document outcomes and survival in infants after amnioinfusion; and suggests that amnioinfusions be withheld in early anhydramnios, pending the findings of the RAFT trial.
Barak D. Richman, JD, PhD; Kevin A. Schulman, MD
JAMA. 2023;329(22):1915-1916. doi:10.1001/jama.2023.6371
This Viewpoint discusses the recently announced monthly Medicare Part B premium hike and the limited role beneficiaries play in decisions about their coverage, and proposes ways to engage Medicare beneficiaries in program decisions.